About Our Speaker

Prof Seligmann is a leading gastrointestinal oncologist. Her clinical and academic work focuses on colorectal cancer, with major contributions to translational research, neoadjuvant/perioperative chemotherapy, and personalized treatment strategies. She is Chief Investigator of several landmark clinical trials, including ARIEL, FOCUS4‑C (completed), and the international FOxTROT programme. An active contributor to international oncology leadership, Prof. Seligmann sits on committees for ESMO, the UK NCRI Colorectal Group, and others and has authored numerous high‑impact publications shaping modern colorectal cancer management.